#Canada #Toronto #financial results #cannabis industry #Auxly Cannabis Group

Auxly's Third Quarter 2026 Financial Results: Strong Growth and Stability

On November 12, 2026, Auxly Cannabis Group Inc. reported its financial performance for the third quarter of 2026, revealing impressive growth in their operational metrics compared to the previous year. The company's net revenue reached $49.5 million, reflecting a robust 24% increase from $39.9 million in Q3 2025. This stellar performance is attributed to higher sales volumes within their core product lines and improved pricing strategies, despite facing some pricing pressure in their vape segment.

Key Highlights of Q3 2026

• - Gross Margin Stability: The company maintained a gross margin of 56% on finished cannabis inventory sold, consistent with the previous quarter. This stability results from ongoing enhancements in cultivation and manufacturing processes, as well as strategic procurement initiatives that positively impacted their cost structure.
• - Increased Adjusted EBITDA: Auxly's adjusted EBITDA grew by an impressive 29%, jumping to $15.8 million, which corresponds to 32% of their net revenue. This increase underscores the company’s focus on operational efficiency and profitability.
• - Positive Net Income: Net income stood at $13.6 million, a decline from $20.5 million reported in Q3 2025; however, this figure included a significant after-tax gain related to the Imperial Debenture Settlement in the previous year. Excluding this gain, net income showed a robust 70% increase year-over-year, thanks to substantial improvements in gross profits and adjusted EBITDA.

CEO Hugo Alves highlighted these results, emphasizing the company’s successful growth strategies and their commitment to maintaining high profitability in a competitive market. Auxly continues to execute a disciplined approach towards innovation and operational excellence, with plans to enhance the capacity of their Leamington facility as part of their growth strategy.

Financial Overview

Auxly's focused approach has allowed them to achieve remarkable financial results:

• - Revenue Growth: The increase in net revenue was primarily driven by strong sales of flower products and improvements in pricing, offset by some margin compression in vape sales.
• - SG&A Expenses: Selling, general, and administrative expenses rose to $13.7 million in Q3 2026, accounting for 27.7% of revenue, down from 29.2% the previous year. This reduction signifies improved operational leverage despite increasing sales efforts to support growth.

Looking Ahead: Growth Strategy and Outlook

As Auxly sets its sights on the future, the company aims to harness its momentum and further expand in both the Canadian and international markets. With increased social acceptance of cannabis and ongoing regulatory developments, the management anticipates favorable long-term conditions for growth.

Auxly plans to invest between $10 million to $12 million of their operational cash flow into capital projects over the next year, with the goal of boosting production capacity by 30% by 2028. This investment is crucial for meeting the growing demand for their diverse range of cannabis brands while maintaining their commitment to quality and efficiency.

Conclusion

In summary, Auxly Cannabis Group Inc.'s Q3 2026 results demonstrate a strong performance characterized by significant revenue growth, controlled costs, and solid profitability. As the company continues to navigate a dynamic and evolving market landscape, its strategic investments and innovation-focused approach position it for sustained success in the cannabis industry. Stakeholders can look forward to further developments as Auxly pursues its ambitious goals in both domestic and international markets.